Currently Viewing:
The Academy of Managed Care Pharmacy (AMCP) 2018
Specialty Drug Pipeline Review Focuses on Competition, Cancer Drugs
April 24, 2018
Dr Robert Navarro Discusses Progress in Shift to Value-Based Care
April 24, 2018
Brian Litten Outlines How Medication Therapy Management Can Address Opioid Misuse
April 24, 2018
Who Decides What Value Looks Like in US Healthcare?
April 24, 2018
Dr Brandon Newman Discusses Payer, Academic Medical Center Collaboration
April 25, 2018
Dr Aimee Tharaldson Discusses Key Market Trends in Specialty Pharmacy
April 25, 2018
Migraines in the US Are More Than Just a Pain Problem
April 25, 2018
Market Access Teams Face New Challenges in Pharma
April 25, 2018
Cardiologist Talks About Value of Monoclonal Antibody Evolocumab
April 26, 2018
Dr Somali Burgess on the Role of Patient-Reported Outcomes in Managed Care Pharmacy
April 26, 2018
Currently Reading
Dr Tina Joseph Discusses Collaborative Practice Agreements Between Pharmacists, Physicians
April 26, 2018
Hemophilia: Treatment Landscape, Costs, and Disease Management
April 26, 2018
Dr Aimee Tharaldson on Recently Approved Specialty Drugs, Upcoming Approvals to Watch
May 05, 2018
Dr Calvin Knowlton Outlines Benefits Seen From Enhanced Medication Therapy Management
May 06, 2018
The Rise of Orphan Drugs for Rare Diseases
May 07, 2018
Dr Robert Navarro Foresees Unintended Consequences From Shift to Value-Based Care
May 12, 2018
Dr Kimberly Lenz: Identifying Patients Most at Risk For Substance Abuse
May 13, 2018
Brian Litten Outlines Challenges With Adopting Medication Therapy Management Services
May 17, 2018
Dr Tina Joseph Outlines Pharmacists' Role in Managing Chronic Diseases, Value-Based Care Models
May 19, 2018
Dr Calvin Knowlton on Innovative Practices in Enhanced Medication Therapy Management
May 20, 2018
Dr Ashley Pappas Discusses Collaboration Between Academic Centers and Payers
May 24, 2018
Dr Robert Navarro on Pharma Implementing Value, Best Practices for Value-Based Contracts
May 25, 2018
Drug Approvals That Dr Aimee Tharaldson Is Keeping an Eye on for 2019
May 27, 2018
Dr Kimberly Lenz on Implementing, Enforcing Appropriate Opioid Prescribing
June 04, 2018

Dr Tina Joseph Discusses Collaborative Practice Agreements Between Pharmacists, Physicians

Tina Joseph, PharmD, BCACP, assistant professor, college of pharmacy, Nova Southeastern University, discusses collaborative practice agreements between pharmacists and physicians, as well as the challenges with, and best practices for, successful implementation.


Tina Joseph, PharmD, BCACP, assistant professor, college of pharmacy, Nova Southeastern University, discusses collaborative practice agreements between pharmacists and physicians, as well as the challenges with, and best practices for, successful implementation.

Transcript

What is a collaborative practice agreement, and how is it used among pharmacists?

A pharmacist collaborative practice agreement is a formal agreement between a licensed provider, who would make diagnoses and supervise patient care, and then they can refer to a pharmacist underneath the protocol, and the pharmacist would be able to change medications, stop medications, start anything that they would want to or labs within a specific scope of practice. This is a really great opportunity for pharmacists to leverage their pharmacy services and help coordinate care.

What barriers exist for successful implementation of collaborative practice agreements?

So, there’s a few barriers to implementing collaborative practice agreements. I think the biggest one is having a strong relationship with the provider you want to have a collaborative practice agreement with. The problem with that is it can take a lot of time to develop trust and make sure that the provider feels very comfortable, but it’s a very important step. Some other barriers could be that pharmacists right now don’t have provider status, so it’s very difficult for pharmacists to bill for their services under Medicare Part D.

A few other barriers could be that a lot of patients don’t fully understand the expanded scope of pharmacists, so when you’re interacting with a patient, it may be the first time they’ve interacted with a pharmacist like that. The last barrier is that there’s a lot of different state laws for collaborative practice agreements. So, depending on the state you’re interacting in, you have to really pay attention to every single law that is particular to that state.

What best practices have been identified for successfully implementing collaborative practice agreements?

There are so many best practices or implementing collaborative practice agreement. We have the Asheville Project, we have the Diabetes Ten City Challenge, and time and time again it shows that pharmacists can improve patient care, reduce costs, and help with preventive care. A few of the other studies actually do help to show that physicians are supportive of pharmacists when they have the opportunity to work with them, and I think there’s a big stigma that physicians really don’t respect pharmacists or think that they’re trained enough. But in the experience form that program and also in my own experience, once the pharmacist can get comfortable with the physician, they feel much more comfortable to work with them and sign a collaborative practice agreement.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up